Retinal Physician

4 weeks ago | retinalphysician.com | Noam Rudnick |Kevin J. Blinder |Scott Friedman |Christina Y. Weng

The DRCR Retina Network (formerly known as the Diabetic Retinopathy Clinical Research Network) was founded in 2002 with the goal of conducting high-quality, large clinical trials focused on diabetic retinopathy (DR) and diabetic macular edema (DME), 2 common causes of vision loss in patients with diabetes.

1 month ago | retinalphysician.com | Michael Singer

Video transcript is below: Hello, my name is Michael Singer, MD, and recently at the Retina World Congress I presented some new data on subcutaneous migaldendranib (Ashvattha Therapeutics), the 24-week phase 2 study results for chronic dosing for the treatment of wet AMD and DME. Obviously, we know there's a big treatment burden for in-office intravitreal injections. This is a paradigm shift.

Mar 1, 2025 | retinalphysician.com | Karen Appold

Zeiss Medical Technology’s newest optical coherence tomography (OCT) device, the Cirrus 6000, provides an efficient and data-driven workflow for ophthalmologists, supported by the largest OCT reference database in the US market, as well as newly enhanced cybersecurity features, says Anuj Kalra, head of the business sector for chronic disease management at Carl Zeiss Meditec in Dublin, California.

Oct 31, 2024 | retinalphysician.com | Rehan M. Hussain

In the digital age, social media has become a powerful communications tool for health care professionals. Although it is common to see refractive or oculoplastic surgeons sharing information on such outlets as Instagram and TikTok, social media platforms also offer retina specialists an opportunity to augment their practices by developing an online presence.

Oct 31, 2024 | retinalphysician.com | Peter Kaiser

In January 2012, I channeled my inner Steve Jobs to cajole electronic medical record companies to “think different” about the future of EMR. It was my first Upfront as editor-in-chief of Retinal Physician. One hundred and seven Upfronts later, it is with a heavy heart that I announce that this is my last. In January, the new editor in chief, Diana Do, MD, of Byers Eye Institute at Stanford, will take over this enviable position and enlighten us in her unique way as she takes the helm.